Interview d'Eric Ducournau, Directeur Général du groupe Pierre Fabre
Pierre Fabre is the 2nd largest dermo-cosmetic laboratory in the world and the 2nd largest private French pharmaceutical group. Its portfolio includes numerous medical franchises and international brands such as Pierre Fabre Oncologie, Pierre Fabre Dermatologie, Eau Thermale Avène, Ducray, Klorane, René Furterer, A-Derma, Naturactive, Elgydium, Inava and Arthrodont. In 2022, Pierre Fabre recorded turnover of €2.7 billion, 69% of which was generated internationally in some 120 countries, and invested more than €170 million in R&D. The group has always been based in the Occitanie region of France and manufactures 90% of its products in France. It employs nearly 9,600 people worldwide. Pierre Fabre is 86% owned by the Pierre Fabre Foundation, a foundation recognized as being of public interest since 1999, and secondarily by its employees through an employee shareholding plan. In 2022, the Group's CSR approach was assessed as "Exemplary" by the independent organization AFNOR Certification for the Engagé RSE (Committed to CSR) label (ISO 26000 standard for sustainable development).